<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-23481" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Infectious Colitis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Azer</surname>
            <given-names>Samy A.</given-names>
          </name>
          <aff>King Saud University, King Khalid UH</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Tuma</surname>
            <given-names>Faiz</given-names>
          </name>
          <aff>Central Michigan University</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Samy Azer declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Faiz Tuma declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>26</day>
          <month>9</month>
          <year>2022</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-23481.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>The management of infectious colitis is complex, and new approaches have been introduced; the basic and clinical aspects of infectious colitis must be clearly defined to achieve satisfactory outcomes. This activity reviews infectious colitis and focuses on the etiology, epidemiology, pathophysiology, evaluation, management, and complications of infectious colitis, and highlights the role of the interprofessional team in improving healthcare outcomes.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology and along with accompanying risk factors for infectious colitis.</p></list-item><list-item><p>Assess&#x000a0;the pathophysiology of infectious colitis.</p></list-item><list-item><p>Evaluate patients for&#x000a0;infectious colitis.</p></list-item><list-item><p>Determine the&#x000a0;management options for infectious colitis, in collaboration with the interprofessional team.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=23481&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=23481">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-23481.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Colonic infection by bacteria, viruses, or parasites results in an inflammatory type of diarrhea, accounting for most cases presenting with acute diarrhea. These patients present with purulent, bloody, and mucoid loose bowel motions, fever, tenesmus, and abdominal pain. Common bacteria causing bacterial colitis include <italic toggle="yes">Campylobacter jejuni (C. jejuni)</italic>, <italic toggle="yes">Salmonella</italic>, <italic toggle="yes">Shigella</italic>, <italic toggle="yes">Escherichia coli (E. coli)</italic>, <italic toggle="yes">Yersinia enterocolitica</italic>, <italic toggle="yes"><italic toggle="yes">Clostridioides</italic>&#x000a0;</italic>(formerly&#x000a0;<italic toggle="yes"><italic toggle="yes">Clostridium</italic></italic>)<italic toggle="yes">&#x000a0;<italic toggle="yes">difficile</italic>&#x000a0;(C. diff)</italic>, and <italic toggle="yes">Mycobacterium tuberculosis</italic>.&#x000a0;Common causes of viral colitis include <italic toggle="yes">Norovirus</italic>, <italic toggle="yes">Rotavirus</italic>, <italic toggle="yes">Adenovirus</italic>, and <italic toggle="yes">Cytomegalovirus</italic>. Parasitic infestation, such as <italic toggle="yes">Entamoeba histolytica</italic>, a protozoan parasite, is capable of invading the colonic mucosa and causing colitis. Sexually transmitted&#x000a0;infection affecting the rectum merits consideration during assessment. These diseases can occur in patients with HIV infection and men who have sex with men and may include <italic toggle="yes">Neisseria gonorrhoeae</italic>, <italic toggle="yes">Chlamydia trachomatis,</italic> Herpes simplex virus (HSV), and <italic toggle="yes">Treponema pallidum</italic>.&#x000a0;</p>
        <p>Patients present with rectal symptoms that mimic inflammatory bowel disease, including rectal pain, tenesmus, bloody mucoid discharge, and urgency. Detailed medical history and identification of specific associated risks are essential in establishing the diagnosis. Stool microscopy culture and endoscopy are crucial to the diagnosis. However, stool culture helps diagnose less than 50% of patients with bacterial colitis, and endoscopic examinations usually reveal nonspecific pathological changes. Therefore, an approach is needed to evaluate and diagnose the cause of colitis and exclude non-infectious causes. This activity discusses current strategies to diagnose and manage infectious colitis, how to make a high index of suspicion based on clinical presentation, and how to use investigation methods to reach a final diagnosis. The etiology, epidemiology, pathophysiology, clinical presentation, evaluation, differential diagnosis, complications, and management of patients with infectious colitis are also reviewed.&#x000a0;</p>
      </sec>
      <sec id="article-23481.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Infectious colitis may result from infection with:</p>
        <list list-type="order">
          <list-item>
            <p><bold>Bacterial infections:</bold>&#x000a0;Including <italic toggle="yes">C. jejuni, Salmonella, Shigella, Escherichia coli </italic>(including the subgroups enterotoxigenic<italic toggle="yes">&#x000a0;E. coli, </italic>enteropathogenic<italic toggle="yes"> E. coli, </italic>enterohemorrhagic<italic toggle="yes"> E. coli, </italic>enteroinvasive<italic toggle="yes"> E. coli, </italic>enteroaggregative<italic toggle="yes"> E. coli), Yersinia enterocolitica, C. diff, </italic>and<italic toggle="yes"> Mycobacterium tuberculosis.</italic></p>
          </list-item>
          <list-item>
            <p><bold>Viral infections:</bold>
<italic toggle="yes">Norovirus, Rotavirus, Adenovirus</italic>, and <italic toggle="yes">Cytomegalovirus</italic> (CMV)</p>
          </list-item>
          <list-item>
            <p><bold>Parasitic infections:</bold>&#x000a0;Such as <italic toggle="yes">Entamoeba histolytica</italic> (which causes amoebic colitis)</p>
          </list-item>
          <list-item>
            <p><bold>Sexually transmitted infections:</bold> Particularly&#x000a0;infections affecting the rectum in patients with HIV infection and men who have sex with men, including&#x000a0;<italic toggle="yes">Neisseria gonorrhoeae</italic>, <italic toggle="yes">Chlamydia trachomatis </italic>(which causes lymphogranuloma venereum), Herpes simplex 1 and 2, and <italic toggle="yes">Treponema pallidum </italic>(which causes syphilis).</p>
          </list-item>
        </list>
        <p>Enterotoxigenic&#x000a0;<italic toggle="yes">E. coli</italic> is the leading cause of traveler&#x02019;s diarrhea. Enteroaggregative&#x000a0;<italic toggle="yes">E. coli</italic> can cause traveler&#x02019;s diarrhea, but it is not the leading cause. Enterohemorrhagic <italic toggle="yes">E. coli</italic> has&#x000a0;2 main serotypes,&#x000a0;<italic toggle="yes">E. coli</italic> O157:H7, and non-O157:H7; the natural reservoirs of both serotypes are cows. Therefore, the infection is related to consuming inadequately cooked beef or contaminated milk or vegetables. They are responsible for outbreaks in developed countries.<xref ref-type="bibr" rid="article-23481.r1">[1]</xref></p>
        <p>Two of these subgroups cause nonbloody diarrhea: enterotoxigenic <italic toggle="yes">E. coli</italic> and enteroaggregative&#x000a0;<italic toggle="yes">E. coli</italic>; both produce enterotoxins that induce chloride and water secretion and inhibit their absorption. However, enterohemorrhagic <italic toggle="yes">E. coli</italic> (both strains E coli O157:H7 and non-O157:H7) causes bloody diarrhea and produces Shiga-like toxins, resulting in a clinical picture similar to <italic toggle="yes">Shigella</italic>
<italic toggle="yes">dysenteriae</italic> infection.<xref ref-type="bibr" rid="article-23481.r2">[2]</xref></p>
        <p>Both enteropathogenic&#x000a0;<italic toggle="yes">E. coli</italic> and enteroinvasive <italic toggle="yes">E. coli</italic> do not produce toxins. Enteropathogenic <italic toggle="yes">E. coli</italic> is responsible for outbreaks, particularly in children under&#x000a0;2 years of age. In contrast, enteroinvasive&#x000a0;<italic toggle="yes">E. coli</italic> causes acute self-limited colitis and is responsible for outbreaks mainly in developing countries. However, the 2014 outbreaks in Nottingham, England, highlight the need for its consideration as a potential pathogen in European foodborne outbreaks.<xref ref-type="bibr" rid="article-23481.r3">[3]</xref> &#x000a0;</p>
        <p>Children (in daycare centers), elderly (in nursing homes), and immunocompromised individuals are susceptible to these infections (see <bold>Image<italic toggle="yes">.&#x000a0;</italic></bold>Radiograph of an Infant With Necrotizing Enterocolitis). The usual modes of infection are the fecal-oral route, animal host, and ingestion of contaminated food and water. Food and water contamination with pathogenic bacteria may cause large outbreaks of diseases.</p>
      </sec>
      <sec id="article-23481.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>
<bold>Bacterial Colitis&#x000a0;</bold>
</p>
        <p>Bacterial colitis&#x000a0;accounts for up to 47% of cases of acute diarrhea.<xref ref-type="bibr" rid="article-23481.r4">[4]</xref>
<italic toggle="yes">C. jejuni&#x000a0;</italic>is the number&#x000a0;one bacterial cause of diarrheal illness worldwide, with an estimated prevalence of 25 to 30 per 100,000 population. For <italic toggle="yes">Salmonella</italic> infection, an estimated 1.2 million annual cases of nontyphoidal salmonellosis occurred in the United States.</p>
        <p>
<bold>Shigellosis</bold>
</p>
        <p>Shigellosis incidence worldwide is reported to be approximately 165 million cases, but mortality has decreased in the last&#x000a0;3 decades because of improvements in laboratory diagnosis and treatment. In the United States, estimates are approximately 500000 cases per year, with 38 to 45 deaths.<xref ref-type="bibr" rid="article-23481.r5">[5]</xref></p>
        <p>
<bold>
<italic toggle="yes">
<italic toggle="yes">Yersinia Enterocolitica</italic>
</italic>
</bold>
</p>
        <p><italic toggle="yes">Yersinia enterocolitica </italic>colitis commonly presents in young children in the winter. In the United States, the estimates are 1 case per 100,000 individuals each year.</p>
        <p>
<bold>
<italic toggle="yes">
<italic toggle="yes">C. Diff</italic>
</italic>
</bold>
</p>
        <p><italic toggle="yes">C. diff&#x000a0;</italic>infection in hospitalized adults in the United States increased from 4.5 cases per 1000 discharges in 2001 to 8.2 cases in 2010 and a mortality rate of 7%.<xref ref-type="bibr" rid="article-23481.r6">[6]</xref>&#x000a0;Another study from the United States on Clostridium infection estimated 500,000 cases in 2011, with 83,000 recurrences and 29,300 deaths.</p>
        <p>
<bold>
<italic toggle="yes">
<italic toggle="yes">Mycobacterium Tuberculosis</italic>
</italic>
</bold>
</p>
        <p><italic toggle="yes">Mycobacterium tuberculosis</italic> is the third most common site of extrapulmonary tuberculosis, accounting for 12.8% of all cases under this category.<xref ref-type="bibr" rid="article-23481.r7">[7]</xref> The recurrence of tuberculosis in developing countries parallels the AIDS epidemic distribution closely.<xref ref-type="bibr" rid="article-23481.r8">[8]</xref> Other factors for increasing rates of tuberculosis in many developed countries are related to the migrant population, deterioration in social conditions, cutbacks in public health surveillance services, and increased prevalence of immune-suppressed individuals (AIDS, those receiving biological agents in diseases such as rheumatoid arthritis, and inflammatory bowel disease).<xref ref-type="bibr" rid="article-23481.r9">[9]</xref></p>
        <p>
<bold>Amebiasis</bold>
</p>
        <p>Amebiasis ranks as the second leading cause of death due to protozoan infection after malaria, Chagas disease, and leishmaniasis.<xref ref-type="bibr" rid="article-23481.r10">[10]</xref></p>
        <p>
<bold>CMV</bold>
</p>
        <p>The prevalence of CMV infection in percent colitis ranges from 21% to 34%.<xref ref-type="bibr" rid="article-23481.r11">[11]</xref> CMV reactivation in patients with severe ulcerative colitis has a reported prevalence of 4.5% to 16.6% and as high as 25% in patients requiring colectomy for severe colitis.</p>
        <p>
<bold>Infectious Proctitis</bold>
</p>
        <p>Infectious proctitis among HIV-positive and HIV-negative men varied and in a recent study was as follows: chlamydia (23% versus 22%, respectively), gonorrhea (13% versus 11%), HSV-1 (14% versus 6%), and HSV-2 (22% versus 12%), lymphogranuloma venereum (8% versus 0.7%), more than 1 infection (18% versus 9%). Approximately&#x000a0;32% of HSV proctitis had external anal ulcerations.<xref ref-type="bibr" rid="article-23481.r12">[12]</xref></p>
      </sec>
      <sec id="article-23481.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>
<bold>
<italic toggle="yes">C. Jejuni</italic>
</bold>
</p>
        <p>Infection with <italic toggle="yes">C. jejuni</italic> is caused by orally ingested contaminated food or water. Several factors influence infections, including the dose of bacteria ingested, the virulence of organisms, and the immunity of the host. The median incubation period is 2 to 4 days. <italic toggle="yes">C. jejuni</italic> multiplies in the bile, invades the epithelial layers, and travels to the lamina propria,&#x000a0;producing a diffuse, bloody, edematous enteritis.</p>
        <p>
<bold>Pseudomembranous Colitis</bold>
</p>
        <p>Pseudomembranous colitis is caused by toxin-producing <italic toggle="yes">C. diff</italic>. The disease develops due to altered normal microflora (usually by antibiotic therapy such as cephalosporin and beta-lactam antibiotics) that enables overgrowth and colonization of the intestine by <italic toggle="yes">C. diff</italic>&#x000a0;and production of its toxins.<xref ref-type="bibr" rid="article-23481.r13">[13]</xref></p>
        <p>
<italic toggle="yes">
<bold>E. Coli</bold>
</italic>
</p>
        <p>
<bold>Enterotoxigenic&#x000a0;<italic toggle="yes">E. coli</italic>&#x000a0;</bold>
</p>
        <p>Enterotoxigenic <italic toggle="yes">E. coli</italic> produces heat-labile (HL) and heat-stable (ST) toxins. The&#x000a0;HL toxins activate adenyl cyclase in enterocytes, resulting in increased&#x000a0;cyclic adenosine monophosphate (cAMP) stimulation of chloride secretion and inhibition of absorption. The ST toxins bind to guanylate cyclase, resulting in increased cyclic guanosine monophosphate (cGMP) and effects on cellular transporters similar to those caused by&#x000a0;HL toxins, resulting in secretory noninflammatory diarrhea (this explains the limited histopathological changes in this infection).<xref ref-type="bibr" rid="article-23481.r14">[14]</xref></p>
        <p>
<bold>Enteropathogenic&#x000a0;<italic toggle="yes">E. coli</italic>&#x000a0;</bold>
</p>
        <p>Enteropathogenic <italic toggle="yes">E. coli</italic> can produce proteins for "attaching" and "effacing" (A/E) lesions, which enable the bacteria to get tightly attached to the enterocyte's apical membranes and cause effacement or loss of the microvilli. As stated earlier, enteropathogenic <italic toggle="yes">E. coli</italic> does not produce toxins, and their underlying mechanism for causing diarrhea is by attaching and effacing lesions.<xref ref-type="bibr" rid="article-23481.r15">[15]</xref></p>
        <p>
<bold>Enterohemorrhagic <italic toggle="yes">E. coli</italic></bold>
</p>
        <p>Enterohemorrhagic E. coli, including&#x000a0;its serotypes, <italic toggle="yes">E. coli</italic> O157:H7 and non-O157:H7, produce Shiga-like toxins similar to Shigella dysenteriae infection. However, <italic toggle="yes">E.&#x000a0;coli</italic> O157:H7 strains are more likely to cause outbreaks than non-O157:H7 serotypes. They produce bloody diarrhea and are responsible for the development of hemolytic-uremic syndrome and ischemic colitis.<xref ref-type="bibr" rid="article-23481.r16">[16]</xref></p>
        <p>
<bold>Enteroinvasive&#x000a0;<italic toggle="yes">E. coli</italic></bold>
</p>
        <p>Enteroinvasive <italic toggle="yes">E. coli</italic> does not produce toxins; it invades enterocytes and causes self-limited colitis. The exact details of its pathogenetic mechanisms are still not fully understood.</p>
        <p>
<bold>Enteroaggregative&#x000a0;<italic toggle="yes">E. coli</italic></bold>
</p>
        <p>Enteroaggregative <italic toggle="yes">E. coli</italic> produces enterotoxins related to Shigella enterotoxins and ST toxins of enterotoxigenic <italic toggle="yes">E. coli</italic>.&#x000a0;It attaches&#x000a0;itself to enterocytes via adherence fimbriae.</p>
        <p>
<bold><italic toggle="yes">Mycobacterium Tuberculosis</italic>&#x000a0;</bold>
</p>
        <p>Immunity to <italic toggle="yes">Mycobacterium tuberculosis</italic> undergoes mediation via T-cells, resulting in macrophage stimulation that kills the bacteria. Reactivation of infection or re-exposure to the bacillus in a sensitized individual, as is the case in most <italic toggle="yes">Mycobacterium tuberculosis</italic> colitis cases, resulting in rapid defense reactions and increased tissue necrosis accompanied by loss of T-cell immunity (tuberculin test in these patients becomes negative although used to be previously positive, which is consistent with fading T-cell protection).<xref ref-type="bibr" rid="article-23481.r17">[17]</xref></p>
        <p>
<bold>CMV&#x000a0;</bold>
</p>
        <p>Primary CMV infection in immunocompetent individuals is usually asymptomatic. However, patients whose immune response is compromised develop symptoms in different body organs, including CMV colitis.</p>
        <p>
<bold>
<italic toggle="yes">Entamoeba Histolytica</italic>
</bold>
</p>
        <p>Research concerning genetics and molecular sciences of <italic toggle="yes">Entamoeba histolytica</italic> have brought new understanding about mechanisms by which the parasite imposes invasive abilities and pathological lesions in the colon and extracolonic organs. Host factors predisposing to infection are also under research.<xref ref-type="bibr" rid="article-23481.r17">[17]</xref></p>
      </sec>
      <sec id="article-23481.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>No significant differences appear in histological biopsies taken from the rectum of patients with different bacterial infections. However, the absence of crypt architecture distortion or basal plasmacytosis helps differentiate acute infectious colitis from chronic inflammation caused by inflammatory bowel disease.</p>
        <p>
<bold>
<italic toggle="yes">E. Coli</italic>
</bold>
</p>
        <p>Infection with <italic toggle="yes">E. coli</italic> O157:H7 may show changes similar to ischemic colitis (small atrophic crypts, hyalinized lamina propria, and fibrin thrombi).&#x000a0;Colonic histopathological changes are limited in enterotoxigenic <italic toggle="yes">E. coli</italic>, enteroinvasive <italic toggle="yes">E. coli</italic>, and enteroaggregative <italic toggle="yes">E. coli</italic> infections.&#x000a0;</p>
        <p>
<bold>
<italic toggle="yes"><italic toggle="yes">Yersinia Enterocolitica</italic>&#x000a0;</italic>
</bold>
</p>
        <p><italic toggle="yes">Yersinia enterocolitica</italic> shows inflammatory changes, ulcerations in the cecum and terminal ileum areas, hyperplasia of Peyer patches, microabscesses, and granulomas. (This condition requires differentiation from Crohn disease and <italic toggle="yes">Mycobacterium tuberculosis</italic> involving the terminal ileum/caecum area.)</p>
        <p>
<bold>
<italic toggle="yes">Mycobacterium Tuberculosis</italic>
</bold>
</p>
        <p>In <italic toggle="yes">Mycobacterium tuberculosis,</italic> characteristic granulomas with central caseation are present; tubercle bacilli are identifiable with acid-fast stains.<xref ref-type="bibr" rid="article-23481.r18">[18]</xref></p>
        <p>
<bold>CMV</bold>
</p>
        <p>The diagnosis of CMV colitis requires histological examination of biopsy tissues taken from the ulcer edge or base. Patients with punched-out ulcers are associated with increased inclusion bodies on histology [Yang H et al 2017]. Colonic mucosal biopsies stained with hematoxylin and eosin (H&#x00026;E) may reveal the typical inclusion associated with CMV colitis, "owl eye appearance" inclusion bodies, which are highly specific for CMV. However, H&#x00026;E staining has low sensitivity compared to immunohistochemistry, considered the gold standard for diagnosing CMV colitis.<xref ref-type="bibr" rid="article-23481.r19">[19]</xref></p>
        <p>
<bold>Syphilitic Proctitis&#x000a0;</bold>
</p>
        <p>The histological features of biopsies taken from the rectum are nonspecific and cannot differentiate syphilitic proctitis and lymphogranuloma venereum. Laboratory tests, including serology and PCR, are essential in making such differentiation.</p>
      </sec>
      <sec id="article-23481.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Detailed medical history and identification of exposure risks are helpful in the diagnosis. It is essential to mention here that individuals with sickle cell anemia, hemolytic anemia, immunosuppression (corticosteroids, chemotherapy, and AIDS), and extremity of age are at a higher risk of <italic toggle="yes">Salmonella</italic> infection. Patients with bacterial colitis present with nonspecific symptoms, including diarrhea, fever, tenesmus, and abdominal pain. Patients with <italic toggle="yes">Yersinia enterocolitica </italic>infection may present a syndrome indistinguishable from acute appendicitis (mesenteric adenitis, mild fever, and ileocecal tenderness).</p>
        <p>
<bold>
<italic toggle="yes">C. Diff</italic>
</bold>
</p>
        <p>The incidence of <italic toggle="yes">C. diff&#x000a0;</italic>is higher in patients with inflammatory bowel disease, particularly ulcerative colitis. Any antibiotic can trigger the disease, but the most common antibiotics responsible are cephalosporins, clindamycin, carbapenems, trimethoprim, sulfonamides, fluoroquinolone, and penicillin combinations.<xref ref-type="bibr" rid="article-23481.r13">[13]</xref></p>
        <p>
<bold>
<italic toggle="yes">Mycobacterial Tuberculosis</italic>
</bold>
</p>
        <p>Patients with <italic toggle="yes">Mycobacterial tuberculosis</italic> may present with abdominal pain, blood per rectum, fever, sweating, tiredness, and pallor. They may give a past&#x000a0;medical history of the treatment of pulmonary tuberculosis. They may have abdominal tenderness in the right iliac fossa (the ileocecal area is the most commonly involved site in intestinal tuberculosis).<xref ref-type="bibr" rid="article-23481.r18">[18]</xref></p>
        <p>
<bold>Viral Colitis&#x000a0;</bold>
</p>
        <p>Viral colitis (<italic toggle="yes">Norovirus, Rotavirus, and Adenovirus</italic>) is common in infants and young children. Affected patients present with nausea, vomiting, watery diarrhea, and abdominal pain. CMV infection is frequently symptomatic in immune-competent patients. Again, symptoms are usually nonspecific, including diarrhea, abdominal pain, fever, malaise, rectal bleeding, and weight loss. However, hematochezia and diarrhea are the most frequent symptoms. Based on clinical presentation, it is difficult to distinguish between ulcerative colitis and CMV colitis.<xref ref-type="bibr" rid="article-23481.r14">[14]</xref></p>
        <p>
<bold>Amoebic Colitis</bold>
</p>
        <p>Amoebic colitis usually presents with diarrhea, mucoid discharge, hematochezia, tenesmus, and abdominal bloating. Contaminated water supplies and poor sanitation are often the cases for traveling overseas to endemic areas and increased risk of fecal-oral transmission of amebas.</p>
        <p>
<bold>Sexually Transmitted Infectious Colitis</bold>
</p>
        <p>Patients with colitis associated with sexually transmitted infection present with anorectal pain, with a purulent, mucoid, or bloody discharge, tenesmus, or urgency. The sexual history is vital in evaluating these patients.&#x000a0;</p>
      </sec>
      <sec id="article-23481.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Diagnosis of colitis centers on clinical findings, laboratory tests, endoscopy, and biopsy. Endoscopy and biopsy should not be the primary investigations; they may be necessary after a critical evaluation of the patient's condition and the results from the initial examination.</p>
        <p>Because infection is a common colitis etiology and can produce clinical presentations indistinguishable from inflammatory bowel disease, microbiological studies and cultures for bacterial and parasitic infestations should be the initial investigations. Laboratory tests should be ordered, including complete blood count, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), arterial blood gases, activated partial thromboplastin time, serum albumin, total protein, blood urea, creatinine, and electrolytes. Polymerase chain reaction (PCR)-based molecular methods (PCR-based multiplex&#x000a0;gastrointestinal pathogens) can help rapidly identify <italic toggle="yes">Salmonella</italic>, <italic toggle="yes">Shigella</italic>, and <italic toggle="yes">Yersinia</italic> investigations from primary stool samples. Abdominal and pelvis CT scans, colonoscopy, tissue biopsies, fecal cultures (multiple specimens), and antimicrobial susceptibility testing should help differentiate infectious from noninfectious colitis causes and guide treatment.<xref ref-type="bibr" rid="article-23481.r15">[15]</xref></p>
        <p>Recently, multidetector CT scans of the abdomen were used to differentiate between inflammatory bowel disease and acute colitis related to bacterial infection. The&#x000a0;5 signs described to diagnose bacterial colitis are (1) continuous distribution, (2) empty colon, (3) absence of fat stranding, (4) absence of a "comb" sign, and (5) absence of enlarged lymph nodes.<xref ref-type="bibr" rid="article-23481.r16">[16]</xref></p>
        <p>
<bold>
<italic toggle="yes">Mycobacterium Tuberculosis Colitis</italic>
</bold>
</p>
        <p>The diagnosis of active <italic toggle="yes">Mycobacterium tuberculosis&#x000a0;</italic>colitis focuses on clinical presentation, clinical examination, and laboratory investigations. A complete blood count may reveal low hemoglobin, leukocytosis, and moderately elevated ESR. Chest X-ray may reveal fibrotic changes, cavitation, or an old scar of pulmonary tuberculosis; an abdominal roentgenogram may reveal a prominent large bowel. Abdominal and pelvis CT scans may show diffuse thickening of the colonic wall, especially of the terminal ileum and the cecum. A colonoscopy usually shows diffuse ulceration throughout the colon, from the&#x000a0;rectum to the cecum. Histopathological biopsies taken from the cecum show caseating granuloma and chronic inflammatory cells. A Mantoux skin test (tuberculin test) is usually requested. This test does not measure immunity to tuberculosis but the degree of hypersensitivity to tuberculin. The results must be interpreted carefully, considering the patient's medical risk factors. Usually, the Mantoux test becomes negative in these patients after being previously positive, indicating the fading of resistance to the organism.<xref ref-type="bibr" rid="article-23481.r17">[17]</xref> PCR testing and cultures of intestinal fluid for bacterial species and acid-fast bacillus are requested.</p>
        <p>
<bold>CMV Colitis</bold>
</p>
        <p>Diagnosis of CMV colitis uses clinical findings, laboratory tests, and endoscopic findings. Endoscopy and tissue CMV-specific immunohistochemistry (IHC) and or PCR CMV DNA quantification are needed to confirm the diagnosis [20].&#x000a0;</p>
        <p>
<bold>Amoebic Colitis</bold>
</p>
        <p>In amoebic colitis, rectosigmoid involvement may present on colonoscopy; however, the cecum is the most commonly involved site, followed by the ascending colon (showing colonic inflammation, erythema, oedematous mucosa, erosions, white or yellow exudates, and ulcerations). The presence of amoebic&#x000a0;trophozoites on histopathological examination or intestinal fluid cultures is important in the diagnosis. Serum <italic toggle="yes">E. histolytica</italic> antibody examination and antibody titer greater than 1:128 is considered positive.<xref ref-type="bibr" rid="article-23481.r17">[17]</xref><xref ref-type="bibr" rid="article-23481.r10">[10]</xref></p>
        <p>
<bold>Sexually transmitted infectious colitis</bold>
</p>
        <p>For patients with suspected sexually transmitted&#x000a0;infections of the rectum, histological features of biopsies taken are non-specific and cannot differentiate syphilitic proctitis and lymphogranuloma venereum. Laboratory tests are usually helpful; these include:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Gonorrhea:</bold> Microscopic examination of smears from the lesions showing Gram-negative diplococci; culture and sensitivity tests of smears taken from lesions</p>
          </list-item>
          <list-item>
            <p><bold>Lymphogranuloma venereum:</bold> Genotyping of <italic toggle="yes">Chlamydia trachomatis</italic> to detect DNA by PCR</p>
          </list-item>
          <list-item>
            <p><bold>Genital or rectal herpes:</bold> Swabs from rectal vesicles or ulcers to detect DNA by PCR.</p>
          </list-item>
          <list-item>
            <p><bold>Syphilis:</bold> Dark-field microscopy, PCR, direct fluorescent antibody test, treponemal antigen-based enzyme immunoassays (EIAs) for immunoglobulin (Ig)G and IgM antibodies, <italic toggle="yes">Treponema pallidum</italic> hemagglutination assay (TPHA), <italic toggle="yes">Treponema pallidum</italic> particle agglutination assay (TPPA), and fluorescent treponemal antibody absorption (FTA-ABS) test&#x000a0;<xref ref-type="bibr" rid="article-23481.r20">[20]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-23481.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>
<bold><italic toggle="yes">C.&#x000a0;jejuni&#x000a0;</italic>or&#x000a0;<italic toggle="yes">Salmonella&#x000a0;</italic></bold>
</p>
        <p>Not all infectious colitis requires antibiotic therapy; patients with mild-to-moderate <italic toggle="yes">C.&#x000a0;jejuni&#x000a0;</italic>or&#x000a0;<italic toggle="yes">Salmonella&#x000a0;</italic>infections do not need antibiotic treatment because the infection is self-limited. Treatment with quinolinic acid antibiotics is only for patients with dysentery and high fever suggestive of bacteremia. Also, patients with AIDS, malignancy, transplantation, prosthetic implants, valvular heart disease, or extreme age require antibiotic therapy.</p>
        <p>
<bold>
<italic toggle="yes">C. Diff&#x000a0;</italic>
</bold>
</p>
        <p>For mild-to-moderate <italic toggle="yes">C. diff&#x000a0;</italic>infection, metronidazole is the preferred treatment. In severe cases of <italic toggle="yes">C. diff&#x000a0;</italic>infection, oral vancomycin is recommended. In complicated cases, oral vancomycin with intravenous metronidazole is the recommendation.<xref ref-type="bibr" rid="article-23481.r18">[18]</xref></p>
        <p>
<bold>Enterohemorrhagic<italic toggle="yes">&#x000a0;E. Coli</italic></bold>
</p>
        <p>In patients, particularly children, with enterohemorrhagic<italic toggle="yes">&#x000a0;E.&#x000a0;coli</italic> (<italic toggle="yes">E.&#x000a0;coli </italic>O157:7H&#x000a0;and non-O157:H7), antibiotics are not recommendations for treating infection because killing the bacteria can lead to increased release of <italic toggle="yes">Shigella</italic> toxins and enhance the risk of the hemolytic uremic syndrome.<xref ref-type="bibr" rid="article-23481.r2">[2]</xref></p>
        <p>
<bold>
<italic toggle="yes">Mycobacterium Tuberculosis&#x000a0;</italic>
</bold>
</p>
        <p>Because of rising multidrug resistance to antituberculous treatment, cases with active <italic toggle="yes">Mycobacterium tuberculosis&#x000a0;</italic>colitis receive therapy with rifampin, isoniazid, pyrazinamide, and ethambutol for 9 to 12 months. The reader should review the recent guidelines by the World Health Organisation on treating developing resistance to tuberculosis.<xref ref-type="bibr" rid="article-23481.r19">[19]</xref>&#x000a0;&#x000a0;</p>
        <p>
<bold>CMV&#x000a0;</bold>
</p>
        <p>Most immunocompetent patients with CMV colitis may need no treatment with antiviral medications. However, antiviral therapy in immunocompetent patients with CMV colitis could be limited to males over the age of 55 who suffer from severe disease and have comorbidities affecting the immune system, such as diabetes mellitus or chronic renal failure; consider an assessment of the colon viral load. The drug of choice is oral or intravenous ganciclovir.<xref ref-type="bibr" rid="article-23481.r19">[19]</xref></p>
        <p>
<bold>
<italic toggle="yes">E. Histolytica</italic>
</bold>
</p>
        <p>Treatment of<italic toggle="yes">&#x000a0;</italic><italic toggle="yes">E. histolytica</italic> is recommended even in asymptomatic individuals. Noninvasive colitis may be treated with paromomycin to eliminate intraluminal cysts. Metronidazole is the antimicrobial of choice for invasive amoebiasis. Medications with longer half-lives (such as tinidazole and ornidazole) allow for shorter treatment periods and are better tolerated. After completing a 10-day course of a nitroimidazole, the patient should be placed on paromomycin to eradicate the luminal parasites. Fulminant amoebic colitis requires the addition of broad-spectrum antibiotics to the treatment due to the risk of bacterial translocation.<xref ref-type="bibr" rid="article-23481.r21">[21]</xref></p>
        <p>
<bold>Gonorrhea</bold>
</p>
        <p>Because of emerging resistance in gonorrhea, current treatment as per current guidelines comprises intramuscular ceftriaxone 500 mg together with an oral dose of azithromycin 1 g. Alternative protocols could be cefixime 400 mg stat or ciprofloxacin 500 mg orally stat.</p>
        <p>
<bold>Lymphogranuloma Venereum</bold>
</p>
        <p>The treatment of lymphogranuloma venereum uses doxycycline orally twice daily for&#x000a0;3 weeks or erythromycin 500 mg 4 times daily for&#x000a0;3 weeks.<xref ref-type="bibr" rid="article-23481.r22">[22]</xref></p>
        <p>
<bold>HSV</bold>
</p>
        <p>Genital&#x000a0;or rectal&#x000a0;HSV is treated with acyclovir 400 mg&#x000a0;3 times daily or valaciclovir 500 mg twice daily for&#x000a0;5 days. Analgesia and saline bathing could soothe the pain. Intravenous therapy is an option if the patient tolerates oral treatment poorly. Consider prolonging treatment if new lesions develop. For recurrent genital or rectal herpes, lesions are usually mild and may need no specific treatment. Symptomatic treatment could help. Challenging cases, such as those with recurrence at short intervals, may require referral for specialized advice. The partner should also have an examination and treatment if the lesion is active.</p>
        <p>
<bold>Syphilis</bold>
</p>
        <p>Syphilis treatment is with penicillin (the drug of choice). A single dose of 2.4 mega units of intramuscular benzathine benzylpenicillin is recommended for early syphilis, or&#x000a0;3 doses at weekly intervals with late syphilis. Doxycycline could be an alternative treatment for individuals sensitive to penicillin. Follow up with patients to ensure clearance from infection and notification are required.<xref ref-type="bibr" rid="article-23481.r23">[23]</xref></p>
      </sec>
      <sec id="article-23481.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnoses for infectious colitis include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Inflammatory bowel disease</p>
          </list-item>
          <list-item>
            <p>Colorectal cancer</p>
          </list-item>
          <list-item>
            <p>Diverticulitis</p>
          </list-item>
          <list-item>
            <p>Ischemic colitis</p>
          </list-item>
          <list-item>
            <p>Irritable bowel disease</p>
          </list-item>
          <list-item>
            <p>Drug-induced colitis</p>
          </list-item>
          <list-item>
            <p>Radiation-associated colitis</p>
          </list-item>
          <list-item>
            <p>Colitis&#x000a0;complicating immune deficiency disorders</p>
          </list-item>
          <list-item>
            <p>Graft-versus-host disease</p>
          </list-item>
          <list-item>
            <p>Acute appendicitis&#x000a0;or ileocecal mass; the differential diagnosis may include: 
<list list-type="bullet"><list-item><p><italic toggle="yes">Yersinia enterocolitica </italic>infection</p></list-item><list-item><p>Crohn disease</p></list-item><list-item><p>Amoebic colitis</p></list-item><list-item><p>Ulcerative colitis</p></list-item><list-item><p>Colorectal cancer involving the cecum</p></list-item></list>
</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-23481.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Most infectious colitis cases last approximately&#x000a0;7 days, with severe cases lingering for several weeks. If left untreated, prolonged disease may be confused for ulcerative colitis.<xref ref-type="bibr" rid="article-23481.r24">[24]</xref></p>
      </sec>
      <sec id="article-23481.s12" sec-type="Complications">
        <title>Complications</title>
        <p>The complications that can manifest with infectious colitis are as follows:</p>
        <list list-type="bullet">
          <list-item>
            <p>Intestinal perforation</p>
          </list-item>
          <list-item>
            <p>Toxic megacolon (<italic toggle="yes">C. diff&#x02013;</italic>associated colitis, <italic toggle="yes">Salmonella</italic>, <italic toggle="yes">Shigella</italic>, <italic toggle="yes">C. jejuni</italic>, <italic toggle="yes">Cytomegalovirus, Rotavirus</italic>), and fulminant form of amebiasis</p>
          </list-item>
          <list-item>
            <p>Pseudomembrane formation (<italic toggle="yes">C. diff</italic>)</p>
          </list-item>
          <list-item>
            <p>Hemorrhagic colitis (enteroinvasive<italic toggle="yes"> E. coli</italic>, enterohemorrhagic<italic toggle="yes"> E. coli</italic>)&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Hemolytic-uremic syndrome (<italic toggle="yes">enterohemorrhagic E. coli</italic>, <italic toggle="yes">C. jejuni</italic>, <italic toggle="yes">Shigella</italic>)</p>
          </list-item>
          <list-item>
            <p>Postinfectious irritable bowel syndrome, dyspepsia</p>
          </list-item>
          <list-item>
            <p>Guillain-Barre syndrome (<italic toggle="yes">C. jejuni</italic>&#x000a0;colitis [serotype HS:19], <italic toggle="yes">Cytomegalovirus</italic> colitis)</p>
          </list-item>
          <list-item>
            <p>Encephalitis, seizure (<italic toggle="yes">Shigella</italic>)</p>
          </list-item>
          <list-item>
            <p>Reactive arthritis (<italic toggle="yes">Shigella</italic>, <italic toggle="yes">C. jejuni</italic>, <italic toggle="yes">Yersinia enterocolitica </italic>colitis<italic toggle="yes">)</italic></p>
          </list-item>
          <list-item>
            <p>Pancreatitis, cholecystitis, meningitis, purulent arthritis (<italic toggle="yes">C. jejuni</italic>)</p>
          </list-item>
          <list-item>
            <p>Septic shock and death (<italic toggle="yes">Shigella, C. diff</italic>)</p>
          </list-item>
          <list-item>
            <p>Elevated serum pancreatic enzymes without clinical pancreatitis (<italic toggle="yes">Salmonella</italic>)</p>
          </list-item>
          <list-item>
            <p>Renal failure, shock (<italic toggle="yes">C. diff</italic>)</p>
          </list-item>
          <list-item>
            <p>Hypoglycemia, hyponatremia (<italic toggle="yes">Shigella</italic>)</p>
          </list-item>
          <list-item>
            <p>Erythema nodosum (<italic toggle="yes">Yersinia enterocolitica</italic>)</p>
          </list-item>
        </list>
        <p>Patients with CMV colitis complicating inflammatory bowel disease may develop severe hemorrhage, megacolon, fulminant colitis, or colon perforation. These complications contribute to the high risk of mortality (see <bold>Image.</bold>&#x000a0;Gross Pathology of Neonatal Necrotizing Enterocolitis).<xref ref-type="bibr" rid="article-23481.r23">[23]</xref><xref ref-type="bibr" rid="article-23481.r25">[25]</xref><xref ref-type="bibr" rid="article-23481.r26">[26]</xref><xref ref-type="bibr" rid="article-23481.r27">[27]</xref><xref ref-type="bibr" rid="article-23481.r23">[23]</xref></p>
      </sec>
      <sec id="article-23481.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients need to receive counseling regarding the importance of antibiotic adherence and any signs of relapse or worsening condition.</p>
      </sec>
      <sec id="article-23481.s14" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>In managing patients presenting with colitis, computed tomography scans, colonoscopy, and biopsies could help differentiate between infectious and noninfectious colitis. However, these investigations are of little help in deciding the infectious agent causing colitis. Microbiological studies, including microscopy, cultures, sensitivity, and PCR DNA tests, are highly valuable in defining an infectious cause's etiology. Treatment of infectious colitis should be individualized depending on the patient&#x02019;s age, causative agent, risk factors, presence of comorbidities, and current guidelines for managing infectious colitis. Antibiotic treatment of children with <italic toggle="yes">E. coli</italic> O157:H7 infection increases the risk of hemolytic uremic syndrome and should be avoided.&#x000a0;</p>
      </sec>
      <sec id="article-23481.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Infectious colitis is complex and requires an interprofessional team for the diagnosis, management, and early detection of complications. The team is comprised&#x000a0;of a gastroenterologist, infectious disease consultant, pathologist, microbiologist, pharmacist, clinical pharmacologist, and general practitioner, which covers the range of expertise needed for managing infectious colitis and handling any complications. All members of the interprofessional healthcare team, including clinicians (MDs, DOs, NPs, PAs), specialists, specialty-trained nursing staff, and pharmacists, need to communicate and collaborate across disciplinary lines in their areas of expertise to keep the entire team informed and current on the status of the case and changes required.&#x000a0;If signs and symptoms fail to resolve, or if signs or symptoms of dehydration develop,&#x000a0;clinicians should&#x000a0;schedule&#x000a0;a follow-up appointement or&#x000a0;possibly recommend emergency department evaluation. Careful assessment of the patient condition and involvement of the healthcare team in evaluation and decision-making is necessary for better outcomes. Patient education should focus on teaching patients to wash hands, eating only well-cooked foods, and drinking bottled water, particularly during traveling, which are the essential preventable measures that patients need to know.&#x000a0;</p>
      </sec>
      <sec id="article-23481.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=23481&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=23481">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/gut-health/infectious-colitis/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=23481">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/23481/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=23481">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-23481.s17">
        <fig id="article-23481.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Radiograph of an Infant With Necrotizing Enterocolitis <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-sa/3.0/deed.en">RadsWiki.net</ext-link></p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Necrotizing_enterocolitis_202" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-23481.s18">
        <fig id="article-23481.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Gross Pathology of Neonatal Necrotizing Enterocolitis. Autopsy&#x000a0;of an infant&#x000a0;with abdominal distention, necrosis, hemorrhage, and peritonitis due to perforation. Edwin P Ewing Jr, MD/Centers for Disease Control and Prevention, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/File:Neonatal_necrotizing_enterocolitis,_gross_pathology_20G0021_lores.jpg">Public Domain</ext-link>, via Wikimedia Commons.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="855_lores" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-23481.s19">
        <title>References</title>
        <ref id="article-23481.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Uhlich</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Sinclair</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Warren</surname>
                <given-names>NG</given-names>
              </name>
              <name>
                <surname>Chmielecki</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Fratamico</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Characterization of Shiga toxin-producing Escherichia coli isolates associated with two multistate food-borne outbreaks that occurred in 2006.</article-title>
            <source>Appl Environ Microbiol</source>
            <year>2008</year>
            <month>Feb</month>
            <volume>74</volume>
            <issue>4</issue>
            <fpage>1268</fpage>
            <page-range>1268-72</page-range>
            <pub-id pub-id-type="pmid">18083883</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23481.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tarr</surname>
                <given-names>PI</given-names>
              </name>
              <name>
                <surname>Gordon</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Chandler</surname>
                <given-names>WL</given-names>
              </name>
            </person-group>
            <article-title>Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome.</article-title>
            <source>Lancet</source>
            <year>2005</year>
            <month>Mar</month>
            <day>19-25</day>
            <volume>365</volume>
            <issue>9464</issue>
            <fpage>1073</fpage>
            <page-range>1073-86</page-range>
            <pub-id pub-id-type="pmid">15781103</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23481.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Newitt</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>MacGregor</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Robbins</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Bayliss</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Chattaway</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Dallman</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ready</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Aird</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Puleston</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Hawker</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Two Linked Enteroinvasive Escherichia coli Outbreaks, Nottingham, UK, June 2014.</article-title>
            <source>Emerg Infect Dis</source>
            <year>2016</year>
            <month>Jul</month>
            <volume>22</volume>
            <issue>7</issue>
            <fpage>1178</fpage>
            <page-range>1178-84</page-range>
            <pub-id pub-id-type="pmid">27314432</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23481.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jewkes</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Larson</surname>
                <given-names>HE</given-names>
              </name>
              <name>
                <surname>Price</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Sanderson</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Davies</surname>
                <given-names>HA</given-names>
              </name>
            </person-group>
            <article-title>Aetiology of acute diarrhoea in adults.</article-title>
            <source>Gut</source>
            <year>1981</year>
            <month>May</month>
            <volume>22</volume>
            <issue>5</issue>
            <fpage>388</fpage>
            <page-range>388-92</page-range>
            <pub-id pub-id-type="pmid">7250751</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23481.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Scallan</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hoekstra</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Angulo</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Tauxe</surname>
                <given-names>RV</given-names>
              </name>
              <name>
                <surname>Widdowson</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Roy</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Griffin</surname>
                <given-names>PM</given-names>
              </name>
            </person-group>
            <article-title>Foodborne illness acquired in the United States--major pathogens.</article-title>
            <source>Emerg Infect Dis</source>
            <year>2011</year>
            <month>Jan</month>
            <volume>17</volume>
            <issue>1</issue>
            <fpage>7</fpage>
            <page-range>7-15</page-range>
            <pub-id pub-id-type="pmid">21192848</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23481.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reveles</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>GC</given-names>
              </name>
              <name>
                <surname>Boyd</surname>
                <given-names>NK</given-names>
              </name>
              <name>
                <surname>Frei</surname>
                <given-names>CR</given-names>
              </name>
            </person-group>
            <article-title>The rise in Clostridium difficile infection incidence among hospitalized adults in the United States: 2001-2010.</article-title>
            <source>Am J Infect Control</source>
            <year>2014</year>
            <month>Oct</month>
            <volume>42</volume>
            <issue>10</issue>
            <fpage>1028</fpage>
            <page-range>1028-32</page-range>
            <pub-id pub-id-type="pmid">25278388</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23481.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cherian</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Lobo</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Sukhlecha</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chawan</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Kshirsagar</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Nair</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>Sawardekar</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Treatment outcome of extrapulmonary tuberculosis under Revised National Tuberculosis Control Programme.</article-title>
            <source>Indian J Tuberc</source>
            <year>2017</year>
            <month>Apr</month>
            <volume>64</volume>
            <issue>2</issue>
            <fpage>104</fpage>
            <page-range>104-108</page-range>
            <pub-id pub-id-type="pmid">28410692</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23481.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Han</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>BI</given-names>
              </name>
              <name>
                <surname>Yeon</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Han</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>Tuberculous colitis. Findings at double-contrast barium enema examination.</article-title>
            <source>Dis Colon Rectum</source>
            <year>1996</year>
            <month>Nov</month>
            <volume>39</volume>
            <issue>11</issue>
            <fpage>1204</fpage>
            <page-range>1204-9</page-range>
            <pub-id pub-id-type="pmid">8918425</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23481.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Karagiannis</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Papaioannou</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Goulas</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Psilopoulos</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Mavrogiannis</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Intestinal tuberculosis in a patient on infliximab treatment.</article-title>
            <source>Gastrointest Endosc</source>
            <year>2008</year>
            <month>Jun</month>
            <volume>67</volume>
            <issue>7</issue>
            <fpage>1178</fpage>
            <page-range>1178-9; discussion 1179</page-range>
            <pub-id pub-id-type="pmid">18329027</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23481.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stanley</surname>
                <given-names>SL</given-names>
              </name>
            </person-group>
            <article-title>Amoebiasis.</article-title>
            <source>Lancet</source>
            <year>2003</year>
            <month>Mar</month>
            <day>22</day>
            <volume>361</volume>
            <issue>9362</issue>
            <fpage>1025</fpage>
            <page-range>1025-34</page-range>
            <pub-id pub-id-type="pmid">12660071</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23481.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wada</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Matsui</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Matake</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Sakurai</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Yamamoto</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kikuchi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Yorioka</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tsuda</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yao</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Yao</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Haraoka</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Iwashita</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Intractable ulcerative colitis caused by cytomegalovirus infection: a prospective study on prevalence, diagnosis, and treatment.</article-title>
            <source>Dis Colon Rectum</source>
            <year>2003</year>
            <month>Oct</month>
            <volume>46</volume>
            <issue>10 Suppl</issue>
            <fpage>S59</fpage>
            <page-range>S59-65</page-range>
            <pub-id pub-id-type="pmid">14530660</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23481.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bissessor</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fairley</surname>
                <given-names>CK</given-names>
              </name>
              <name>
                <surname>Read</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Denham</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Bradshaw</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>The etiology of infectious proctitis in men who have sex with men differs according to HIV status.</article-title>
            <source>Sex Transm Dis</source>
            <year>2013</year>
            <month>Oct</month>
            <volume>40</volume>
            <issue>10</issue>
            <fpage>768</fpage>
            <page-range>768-70</page-range>
            <pub-id pub-id-type="pmid">24275725</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23481.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Slimings</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Riley</surname>
                <given-names>TV</given-names>
              </name>
            </person-group>
            <article-title>Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis.</article-title>
            <source>J Antimicrob Chemother</source>
            <year>2014</year>
            <month>Apr</month>
            <volume>69</volume>
            <issue>4</issue>
            <fpage>881</fpage>
            <page-range>881-91</page-range>
            <pub-id pub-id-type="pmid">24324224</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23481.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Levin</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Yaari</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Stoff</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Caplan</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Wolf</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Israeli</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis of Cytomegalovirus Infection during Exacerbation of Ulcerative Colitis.</article-title>
            <source>Digestion</source>
            <year>2017</year>
            <volume>96</volume>
            <issue>3</issue>
            <fpage>142</fpage>
            <page-range>142-148</page-range>
            <pub-id pub-id-type="pmid">28848127</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23481.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jessurun</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>The Differential Diagnosis of Acute Colitis: Clues to a Specific Diagnosis.</article-title>
            <source>Surg Pathol Clin</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>10</volume>
            <issue>4</issue>
            <fpage>863</fpage>
            <page-range>863-885</page-range>
            <pub-id pub-id-type="pmid">29103537</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23481.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Plastaras</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Vuitton</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Badet</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Koch</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Di Martino</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Delabrousse</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Acute colitis: differential diagnosis using multidetector CT.</article-title>
            <source>Clin Radiol</source>
            <year>2015</year>
            <month>Mar</month>
            <volume>70</volume>
            <issue>3</issue>
            <fpage>262</fpage>
            <page-range>262-9</page-range>
            <pub-id pub-id-type="pmid">25522900</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23481.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stauffer</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Ravdin</surname>
                <given-names>JI</given-names>
              </name>
            </person-group>
            <article-title>Entamoeba histolytica: an update.</article-title>
            <source>Curr Opin Infect Dis</source>
            <year>2003</year>
            <month>Oct</month>
            <volume>16</volume>
            <issue>5</issue>
            <fpage>479</fpage>
            <page-range>479-85</page-range>
            <pub-id pub-id-type="pmid">14502002</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23481.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Di</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Bai</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Ni</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Liang</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>A meta-analysis of metronidazole and vancomycin for the treatment of Clostridium difficile infection, stratified by disease severity.</article-title>
            <source>Braz J Infect Dis</source>
            <year>2015</year>
            <season>Jul-Aug</season>
            <volume>19</volume>
            <issue>4</issue>
            <fpage>339</fpage>
            <page-range>339-49</page-range>
            <pub-id pub-id-type="pmid">26001980</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23481.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Falzon</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Sch&#x000fc;nemann</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Harausz</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Gonz&#x000e1;lez-Angulo</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Lienhardt</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Jaramillo</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Weyer</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update.</article-title>
            <source>Eur Respir J</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>49</volume>
            <issue>3</issue>
            <pub-id pub-id-type="pmid">28331043</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23481.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hook</surname>
                <given-names>EW</given-names>
              </name>
            </person-group>
            <article-title>Syphilis.</article-title>
            <source>Lancet</source>
            <year>2017</year>
            <month>Apr</month>
            <day>15</day>
            <volume>389</volume>
            <issue>10078</issue>
            <fpage>1550</fpage>
            <page-range>1550-1557</page-range>
            <pub-id pub-id-type="pmid">27993382</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23481.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Haque</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Huston</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Hughes</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Houpt</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Petri</surname>
                <given-names>WA</given-names>
              </name>
            </person-group>
            <article-title>Amebiasis.</article-title>
            <source>N Engl J Med</source>
            <year>2003</year>
            <month>Apr</month>
            <day>17</day>
            <volume>348</volume>
            <issue>16</issue>
            <fpage>1565</fpage>
            <page-range>1565-73</page-range>
            <pub-id pub-id-type="pmid">12700377</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23481.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stoner</surname>
                <given-names>BP</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>SE</given-names>
              </name>
            </person-group>
            <article-title>Lymphogranuloma Venereum 2015: Clinical Presentation, Diagnosis, and Treatment.</article-title>
            <source>Clin Infect Dis</source>
            <year>2015</year>
            <month>Dec</month>
            <day>15</day>
            <volume>61 Suppl 8</volume>
            <fpage>S865</fpage>
            <page-range>S865-73</page-range>
            <pub-id pub-id-type="pmid">26602624</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23481.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dean</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gill</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Buchan</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Salmonella colitis as an unusual cause of elevated serum lipase.</article-title>
            <source>Am J Emerg Med</source>
            <year>2017</year>
            <month>May</month>
            <volume>35</volume>
            <issue>5</issue>
            <fpage>800.e5</fpage>
            <page-range>800.e5-800.e6</page-range>
            <pub-id pub-id-type="pmid">27865572</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23481.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Papaconstantinou</surname>
                <given-names>HT</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>Bacterial colitis.</article-title>
            <source>Clin Colon Rectal Surg</source>
            <year>2007</year>
            <month>Feb</month>
            <volume>20</volume>
            <issue>1</issue>
            <fpage>18</fpage>
            <page-range>18-27</page-range>
            <pub-id pub-id-type="pmid">20011357</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23481.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Autenrieth</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Baumgart</surname>
                <given-names>DC</given-names>
              </name>
            </person-group>
            <article-title>Toxic megacolon.</article-title>
            <source>Inflamm Bowel Dis</source>
            <year>2012</year>
            <month>Mar</month>
            <volume>18</volume>
            <issue>3</issue>
            <fpage>584</fpage>
            <page-range>584-91</page-range>
            <pub-id pub-id-type="pmid">22009735</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23481.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Horiki</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Furukawa</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kitade</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sakuno</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Katsurahara</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Harada</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Tano</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yamada</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Hamada</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Inoue</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Tanaka</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Gabazza</surname>
                <given-names>EC</given-names>
              </name>
              <name>
                <surname>Ishii</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Fukuda</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Omata</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Fujita</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Tachibana</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Takei</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Endoscopic findings and lesion distribution in amebic colitis.</article-title>
            <source>J Infect Chemother</source>
            <year>2015</year>
            <month>Jun</month>
            <volume>21</volume>
            <issue>6</issue>
            <fpage>444</fpage>
            <page-range>444-8</page-range>
            <pub-id pub-id-type="pmid">25787830</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23481.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>T&#x000f6;rnblom</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Holmvall</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Svenungsson</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Lindberg</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Gastrointestinal symptoms after infectious diarrhea: a five-year follow-up in a Swedish cohort of adults.</article-title>
            <source>Clin Gastroenterol Hepatol</source>
            <year>2007</year>
            <month>Apr</month>
            <volume>5</volume>
            <issue>4</issue>
            <fpage>461</fpage>
            <page-range>461-4</page-range>
            <pub-id pub-id-type="pmid">17445752</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
